Ivermectin treatment for Strongyloides infection in patients with COVID-19

Ivermectin treatment for Strongyloides infection in patients with COVID-19

Ivermectin, an antiparasitic agent, is not recommended for prophylaxis or treatment of coronavirus disease 2019 (COVID-19). Inappropriate use of ivermectin for treatment of COVID-19 may make it less available for patients with serious parasitic infections who could benefit from its use and worsen th...

Full description

Bibliographic Details
Main Authors: Elizabeth Leung, Sumit Raybardhan, Christopher Graham, Caroline Nott, Bradley J Langford, Nisha Andany, William Ciccotelli, Sumon Chakrabarti, Isaac I Bogoch, Wayne L Gold, Menaka Pai, Andrew M Morris, Anne McCarthy
Format: Article
Language:English
Published: Public Health Agency of Canada 2021-07-01
Series:Canada Communicable Disease Report
Subjects:
covid-19
strongyloides
ivermectin
immunosuppression
corticosteroids
il-6 inhibitors
strongyloidiasis
Online Access:https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/covid-19-treating-strongyloides-ivermectin-patients.html

Internet

https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/covid-19-treating-strongyloides-ivermectin-patients.html

Similar Items